|Articles|December 10, 2019
WCG Launches AIMS 4.1 Platform
Advertisement
WCG ACI Clinical has launched the latest iteration of its proprietary AIMS. AIMS 4.1 offers users of WCG's endpoint adjudication solutions an enhanced interface and workflow experience.
To learn more about AIMS 4.1, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Utilizing Tech Tools to Accelerate Drug Development
3
Streamlining Clinical Data to Reduce Site and Participant Burden
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
